Antineoplastic resistance

Resistance to cancer treatment

Antineoplastic resistance refers to the ability of cancer cells to resist the effects of chemotherapy and other antineoplastic agents. This resistance can be intrinsic or acquired and poses a significant challenge in the treatment of cancer.

Mechanisms of Resistance

Antineoplastic resistances

Cancer cells can develop resistance to antineoplastic agents through various mechanisms:

Drug Efflux

One of the primary mechanisms is the increased efflux of drugs from cancer cells. This is often mediated by ABC transporters, such as P-glycoprotein, which pump drugs out of the cell, reducing their intracellular concentration and effectiveness.

Drug Inactivation

Cancer cells can also develop the ability to inactivate drugs. This can occur through the increased expression of enzymes that metabolize and neutralize the drug, rendering it ineffective.

Alteration of Drug Targets

Mutations in the target molecules of antineoplastic drugs can lead to resistance. For example, mutations in the tyrosine kinase domain of the BCR-ABL protein can confer resistance to imatinib in chronic myeloid leukemia.

DNA Repair

Enhanced DNA repair mechanisms can allow cancer cells to survive the DNA-damaging effects of certain chemotherapeutic agents. This includes increased expression of DNA repair enzymes that correct the damage caused by drugs like cisplatin.

Cell Death Inhibition

Cancer cells can evade apoptosis, or programmed cell death, which is a common mechanism of action for many antineoplastic agents. Alterations in apoptotic pathways, such as overexpression of anti-apoptotic proteins like Bcl-2, can lead to resistance.

Types of Resistance

Intrinsic Resistance

Intrinsic resistance refers to the natural ability of cancer cells to resist treatment from the outset. This can be due to genetic mutations present in the cancer cells before treatment begins.

Acquired Resistance

Acquired resistance develops after exposure to chemotherapy. Cancer cells may initially respond to treatment but eventually develop resistance through genetic mutations or adaptive responses.

Strategies to Overcome Resistance

Combination Therapy

Using a combination of drugs with different mechanisms of action can help prevent or overcome resistance. This approach reduces the likelihood that cancer cells will simultaneously develop resistance to all agents.

Targeted Therapy

Targeted therapies are designed to specifically attack cancer cells with certain genetic mutations or characteristics, minimizing damage to normal cells and reducing the potential for resistance.

Inhibition of Resistance Mechanisms

Developing inhibitors that target specific resistance mechanisms, such as ABC transporters or DNA repair enzymes, can enhance the effectiveness of existing therapies.

Related Pages

• Chemotherapy
• Cancer
• Drug resistance
• Targeted therapy